<?xml version='1.0' encoding='utf-8'?>
<document id="18175959"><sentence text="Contribution of multidrug resistance-associated protein 2 to secretory intestinal transport of organic anions." /><sentence text="Various mechanisms can influence the intestinal absorption and oral bioavailability of drugs" /><sentence text=" The barrier effects of efflux transporters may be one of the critical factors limiting the bioavailability of certain drugs" /><sentence text=" It has been reported that multidrug resistance-associated protein 2 (Mrp2) is expressed in the mucosal membrane of the epithelium of the small intestine and secretes various drugs into the jejunum lumen" /><sentence text=" However, it is possible that total intestinal secretion of Mrp2 substrates is accounted for the contribution of Mrp2 and other transporter(s) to the intestinal secretion of Mrp2 substrates" /><sentence text=" In this study, we found that phenolsulfonphthalein and pravastatin, both Mrp2 substrates, are transported by different transport systems in the intestine"><entity charOffset="30-51" id="DDI-PubMed.18175959.s6.e0" text="phenolsulfonphthalein" /><entity charOffset="56-67" id="DDI-PubMed.18175959.s6.e1" text="pravastatin" /><pair ddi="false" e1="DDI-PubMed.18175959.s6.e0" e2="DDI-PubMed.18175959.s6.e0" /><pair ddi="false" e1="DDI-PubMed.18175959.s6.e0" e2="DDI-PubMed.18175959.s6.e1" /></sentence><sentence text=" These results suggest that contribution of transporters to the drug transport may be a critical factor affecting drug disposition and drug-drug interaction" /><sentence text=" In addition to evaluating the substrate specificity of a transporter, it is important to be aware of the contribution of a transporter to drug disposition" /><sentence text="" /></document>